Clinical Trial Update: Digoxin Medulloblastoma Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating digoxin for medulloblastoma is currently recruiting at H. Lee Moffitt Cancer Center; the study targets Medulloblastoma and its…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Drugs mentioned

• DIGOXIN (Digoxin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH | Phase 2 | Status: RECRUITING